-
Product Insights
NewPTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTA Peripheral DCB Catheters Pipeline Market Report Overview A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels,...
-
Product Insights
Lafora Disease (Unverricht Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Lafora Disease (Unverricht Disease) - Drugs In Development, 2023’, provides an overview of the Lafora Disease (Unverricht Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lafora Disease (Unverricht Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Menkes Disease (Kinky Hair Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Menkes Disease (Kinky Hair Disease) - Drugs In Development, 2023’, provides an overview of the Menkes Disease (Kinky Hair Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Menkes Disease (Kinky Hair Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Mu Type Opioid Receptor – Drugs In Development, 2023
Global Markets Direct’s Mu Type Opioid Receptor provides in depth analysis on Mu Type Opioid Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Mu Type Opioid...
-
Product Insights
Coagulation Factor X – Drugs In Development, 2023
Global Markets Direct’s Coagulation Factor X provides in depth analysis on Coagulation Factor X targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Coagulation Factor X targeted therapeutics...
-
Product Insights
Kappa Type Opioid Receptor – Drugs In Development, 2023
Global Markets Direct’s Kappa Type Opioid Receptor provides in depth analysis on Kappa Type Opioid Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Kappa Type Opioid...
-
Product Insights
Triggering Receptor Expressed On Myeloid Cells 1 – Drugs In Development, 2023
Global Markets Direct’s Triggering Receptor Expressed On Myeloid Cells 1 provides in depth analysis on Triggering Receptor Expressed On Myeloid Cells 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Thromboembolic Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Thromboembolic Disease - Drugs In Development, 2023’, provides an overview of the Thromboembolic Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thromboembolic Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Raynauds Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Raynauds Disease - Drugs In Development, 2023’, provides an overview of the Raynauds Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Raynauds Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Anemia of Chronic Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Anemia of Chronic Disease - Drugs In Development, 2023’, provides an overview of the Anemia of Chronic Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anemia of Chronic Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...